340 related articles for article (PubMed ID: 29637913)
1. Thiazolidinediones and risk of colorectal cancer in patients with diabetes mellitus: A meta-analysis.
Liu Y; Jin PP; Sun XC; Hu TT
Saudi J Gastroenterol; 2018; 24(2):75-81. PubMed ID: 29637913
[TBL] [Abstract][Full Text] [Related]
2. Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis.
Singh S; Singh PP; Singh AG; Murad MH; McWilliams RR; Chari ST
Am J Gastroenterol; 2013 Apr; 108(4):510-9; quiz 520. PubMed ID: 23399556
[TBL] [Abstract][Full Text] [Related]
3. Thiazolidinedione use and cancer incidence in type 2 diabetes: a systematic review and meta-analysis.
Colmers IN; Bowker SL; Johnson JA
Diabetes Metab; 2012 Dec; 38(6):475-84. PubMed ID: 23041441
[TBL] [Abstract][Full Text] [Related]
4. Anti-diabetic medications do not influence risk of lung cancer in patients with diabetes mellitus: a systematic review and meta-analysis.
Nie SP; Chen H; Zhuang MQ; Lu M
Asian Pac J Cancer Prev; 2014; 15(16):6863-9. PubMed ID: 25169538
[TBL] [Abstract][Full Text] [Related]
5. Antidiabetic medications and the risk of colorectal cancer in patients with diabetes mellitus: a systematic review and meta-analysis.
Singh S; Singh H; Singh PP; Murad MH; Limburg PJ
Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2258-68. PubMed ID: 24042261
[TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus and the incidence and mortality of colorectal cancer: a meta-analysis of 24 cohort studies.
Luo W; Cao Y; Liao C; Gao F
Colorectal Dis; 2012 Nov; 14(11):1307-12. PubMed ID: 23046351
[TBL] [Abstract][Full Text] [Related]
7. Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis.
Zhang Z; Zhang X; Korantzopoulos P; Letsas KP; Tse G; Gong M; Meng L; Li G; Liu T
BMC Cardiovasc Disord; 2017 Apr; 17(1):96. PubMed ID: 28381265
[TBL] [Abstract][Full Text] [Related]
8. Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials.
Hernandez AV; Usmani A; Rajamanickam A; Moheet A
Am J Cardiovasc Drugs; 2011; 11(2):115-28. PubMed ID: 21294599
[TBL] [Abstract][Full Text] [Related]
9. Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.
Singh S; Singh PP; Singh AG; Murad MH; Sanchez W
Am J Gastroenterol; 2013 Jun; 108(6):881-91; quiz 892. PubMed ID: 23381014
[TBL] [Abstract][Full Text] [Related]
10. Thiazolidinedione therapy and breast cancer risk in diabetic women: A systematic review and meta-analysis.
Du R; Lin L; Cheng D; Xu Y; Xu M; Chen Y; Wang W; Bi Y; Li D; Lu J
Diabetes Metab Res Rev; 2018 Feb; 34(2):. PubMed ID: 29125710
[TBL] [Abstract][Full Text] [Related]
11. Cancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysis.
Bosetti C; Rosato V; Buniato D; Zambon A; La Vecchia C; Corrao G
Oncologist; 2013; 18(2):148-56. PubMed ID: 23345544
[TBL] [Abstract][Full Text] [Related]
12. Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six-year population-based cohort study.
Lin HC; Hsu YT; Kachingwe BH; Hsu CY; Uang YS; Wang LH
J Clin Pharm Ther; 2014 Aug; 39(4):354-60. PubMed ID: 24661226
[TBL] [Abstract][Full Text] [Related]
13. Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus.
Chang CH; Lin JW; Wu LC; Lai MS; Chuang LM; Chan KA
Hepatology; 2012 May; 55(5):1462-72. PubMed ID: 22135104
[TBL] [Abstract][Full Text] [Related]
14. Decreased risk of Parkinson's disease in diabetic patients with thiazolidinediones therapy: An exploratory meta-analysis.
Zhu Y; Pu J; Chen Y; Zhang B
PLoS One; 2019; 14(10):e0224236. PubMed ID: 31639149
[TBL] [Abstract][Full Text] [Related]
15. Insulin therapy and the risk of colorectal cancer in patients with type 2 diabetes: a meta-analysis of observational studies.
Bu WJ; Song L; Zhao DY; Guo B; Liu J
Br J Clin Pharmacol; 2014 Aug; 78(2):301-9. PubMed ID: 25099257
[TBL] [Abstract][Full Text] [Related]
16. Association of gallstone disease with risk of colorectal cancer: a systematic review and meta-analysis of observational studies.
Polychronidis G; Siddiqi H; Ali Ahmed F; Papatheodorou S; Giovannucci EL; Song M
Int J Epidemiol; 2023 Oct; 52(5):1424-1434. PubMed ID: 37071919
[TBL] [Abstract][Full Text] [Related]
17. Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies.
Liu Y; Tang W; Wang J; Xie L; Li T; He Y; Deng Y; Peng Q; Li S; Qin X
Cancer Causes Control; 2014 Feb; 25(2):237-49. PubMed ID: 24265089
[TBL] [Abstract][Full Text] [Related]
18. Allergies and risk of colorectal cancer: a systematic review and meta-analysis of observational studies.
Ye J; Talaiti A; Ma Y; Zhang Q; Ma L; Zheng H
Oncotarget; 2017 Feb; 8(9):14646-14654. PubMed ID: 28086228
[TBL] [Abstract][Full Text] [Related]
19. Addition of thiazolidinedione or exenatide to oral agents in type 2 diabetes: a meta-analysis.
Pinelli NR; Cha R; Brown MB; Jaber LA
Ann Pharmacother; 2008 Nov; 42(11):1541-51. PubMed ID: 18957626
[TBL] [Abstract][Full Text] [Related]
20. Possible Protective Effects of Thiazolidinediones Antidiabetic Drugs in Colorectal Cancer.
Bahrambeigi S; Badalzadeh R; Shafiei-Irannejad V; Alizadeh A
Crit Rev Oncog; 2019; 24(3):251-258. PubMed ID: 32422023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
